ProAir® Digihaler™ (albuterol sulfate) – New drug approval
December 21, 2018 - Teva announced the FDA approval of ProAir Digihaler (albuterol sulfate) inhalation powder, for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease and for prevention of exercise-induced bronchospasm in patients 4 years of age and older.
Top